History of fecal transplantation; camel feces contains limited amounts of Bacillus subtilis spores and likely has no traditional role in the treatment of dysentery.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
19
04
2022
accepted:
23
07
2022
entrez:
10
8
2022
pubmed:
11
8
2022
medline:
13
8
2022
Statut:
epublish
Résumé
A widely cited story on the origins of fecal transplantation suggests that German soldiers in North Africa used camel feces containing Bacillus subtilis to treat dysentery in World War 2. We investigated if this story is accurate and if there is sufficient Bacillus subtilis in camel feces to be potentially therapeutic. A literature analysis shows that all references to the story are based on a single review paper that mentions the use of camel feces in passing and only provides indirect evidence for this claim. An extensive literature search failed to find independent evidence that camel feces has traditionally been used in the treatment of dysentery in North Africa. With 16S sequence analysis we did not detect Bacillus subtilis in feces from two different Egyptian camels. Using a more sensitive culture-based assay we could detect low amounts of Bacillus subtilis spores in these fecal samples, with comparable concentrations to those present in human feces and soil. Because we could not find evidence for the use of camel feces in the treatment of diarrhea and because we show that only low amounts of Bacillus subtilis spores are present in camel feces, we conclude that the use of camel feces should no longer be mentioned in the context of origins of fecal transplantation.
Identifiants
pubmed: 35947590
doi: 10.1371/journal.pone.0272607
pii: PONE-D-22-10655
pmc: PMC9365175
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0272607Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Saudi Pharm J. 2021 Jul;29(7):740-750
pubmed: 34400869
Surgery. 1958 Nov;44(5):854-9
pubmed: 13592638
PLoS One. 2013 Apr 22;8(4):e61217
pubmed: 23630581
Anaerobe. 2019 Dec;60:102092
pubmed: 31472233
Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6
pubmed: 23193283
Benef Microbes. 2018 Apr 25;9(3):357-365
pubmed: 29482338
Nature. 2018 Oct;562(7728):532-537
pubmed: 30305736
Perspect Biol Med. 2001 Fall;44(4):594-607
pubmed: 11600805
Annu Rev Microbiol. 1998;52:165-90
pubmed: 9891797
Food Microbiol. 2011 Apr;28(2):214-20
pubmed: 21315976
Gastroenterology. 2013 Nov;145(5):946-53
pubmed: 24018052
J Bacteriol. 2006 Apr;188(7):2692-700
pubmed: 16547057
Res Microbiol. 2009 Jul-Aug;160(6):375-9
pubmed: 19589385
Annu Rev Med. 2019 Jan 27;70:335-351
pubmed: 30403550
Nat Rev Gastroenterol Hepatol. 2021 Jan;18(1):67-80
pubmed: 32843743
Int Microbiol. 2019 Dec;22(4):429-435
pubmed: 30875036
Aliment Pharmacol Ther. 2017 Sep;46(5):479-493
pubmed: 28707337
Gastroenterology. 2019 Sep;157(3):624-636
pubmed: 31220424
J Appl Microbiol. 2006 Sep;101(3):514-25
pubmed: 16907802
FEMS Microbiol Rev. 2005 Sep;29(4):813-35
pubmed: 16102604
Food Sci Biotechnol. 2019 Oct 8;28(5):1297-1305
pubmed: 31695928